Liver Diseases  >>  peginterferon lambda-1a (BMS-914143)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
peginterferon lambda-1a (BMS-914143) / Eiger, Stanford University
NCT00565539: Study of PEG-rIL-29 (or PEG-IFN Lambda) in Subjects With Chronic Hepatitis C Virus Infection

Completed
1
56
US, Canada
PEGylated recombinant interleukin 29 (PEG-rIL-29), PEGylated interferon lambda (PEG-IFN lambda)
ZymoGenetics
Hepatitis C, Chronic
10/09
10/09
NCT01708889: Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal Dysfunction

Completed
1
43
US
BMS-914143 (Peginterferon Lambda-1a), Lambda
Bristol-Myers Squibb
Chronic Hepatitis B Virus Infection, Chronic Hepatitis C Virus Infection
02/13
02/13

Download Options